BeOne Announces US$7.94 Million RSU Grant Covering 0.02% of Share Capital

Bulletin Express05-13

On 8 May 2026, BeOne Medicines Ltd. approved the award of 25,436 restricted share units (RSUs), equivalent to 330,668 ordinary shares, to 201 employees under its Fourth Amended and Restated 2016 Share Option and Incentive Plan. The new grant represents approximately 0.02% of the company’s total issued shares as of the announcement date.

The RSUs carry no consideration cost to recipients and will vest in four equal tranches—25% on each anniversary of the grantee’s start-date anniversary or, for four specific employees, each anniversary of 30 April 2026—subject to continued employment. Certain termination or change-of-control events could accelerate vesting.

Based on the 8 May 2026 closing price of US$312.12 per American Depositary Share (each ADS represents 13 ordinary shares), the award has a notional market value of approximately US$7.94 million (HK$62.19 million).

The grant does not impose performance targets or clawback provisions, aligning with prevailing market practice and the objectives of the 2016 plan. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers exceeding relevant Hong Kong Listing Rules thresholds.

Following this transaction, 61.51 million ordinary shares remain available for future equity awards under the incentive plan, including 20.40 million reserved for the consultant sub-limit.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165601096?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165601096","market":"hk","top_or_hot":-1,"title":"BeOne Announces US$7.94 Million RSU Grant Covering 0.02% of Share Capital","media":"Bulletin Express","content":"<p>On 8 May 2026, BeOne Medicines Ltd. approved the award of 25,436 restricted share units (RSUs), equivalent to 330,668 ordinary shares, to 201 employees under its Fourth Amended and Restated 2016 Share Option and Incentive Plan. The new grant represents approximately 0.02% of the company’s total issued shares as of the announcement date.</p>\n<p>The RSUs carry no consideration cost to recipients and will vest in four equal tranches—25% on each anniversary of the grantee’s start-date anniversary or, for four specific employees, each anniversary of 30 April 2026—subject to continued employment. Certain termination or change-of-control events could accelerate vesting.</p>\n<p>Based on the 8 May 2026 closing price of US$312.12 per American Depositary Share (each ADS represents 13 ordinary shares), the award has a notional market value of approximately US$7.94 million (HK$62.19 million).</p>\n<p>The grant does not impose performance targets or clawback provisions, aligning with prevailing market practice and the objectives of the 2016 plan. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers exceeding relevant Hong Kong Listing Rules thresholds.</p>\n<p>Following this transaction, 61.51 million ordinary shares remain available for future equity awards under the incentive plan, including 20.40 million reserved for the consultant sub-limit.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Announces US$7.94 Million RSU Grant Covering 0.02% of Share Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Announces US$7.94 Million RSU Grant Covering 0.02% of Share Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-13 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 8 May 2026, BeOne Medicines Ltd. approved the award of 25,436 restricted share units (RSUs), equivalent to 330,668 ordinary shares, to 201 employees under its Fourth Amended and Restated 2016 Share Option and Incentive Plan. The new grant represents approximately 0.02% of the company’s total issued shares as of the announcement date.</p>\n<p>The RSUs carry no consideration cost to recipients and will vest in four equal tranches—25% on each anniversary of the grantee’s start-date anniversary or, for four specific employees, each anniversary of 30 April 2026—subject to continued employment. Certain termination or change-of-control events could accelerate vesting.</p>\n<p>Based on the 8 May 2026 closing price of US$312.12 per American Depositary Share (each ADS represents 13 ordinary shares), the award has a notional market value of approximately US$7.94 million (HK$62.19 million).</p>\n<p>The grant does not impose performance targets or clawback provisions, aligning with prevailing market practice and the objectives of the 2016 plan. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers exceeding relevant Hong Kong Listing Rules thresholds.</p>\n<p>Following this transaction, 61.51 million ordinary shares remain available for future equity awards under the incentive plan, including 20.40 million reserved for the consultant sub-limit.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1165601096","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165601096","pubTimestamp":1778662974,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 8 May 2026, BeOne Medicines Ltd. approved the award of 25,436 restricted share units (RSUs), equivalent to 330,668 ordinary shares, to 201 employees under its Fourth Amended and Restated 2016...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne宣布授予794万美元受限制股份单位，占股本的0.02%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"On 8 May 2026, BeOne Medicines Ltd. approved the award of 25,436 restricted share units (RSUs), equivalent to 330,668 ordinary shares, to 201 employees under its Fourth Amended and Restated 2016 Share Option and Incentive Plan. The new grant represents approximately 0.02% of the company’s total issued shares as of the announcement date.\nThe RSUs carry no consideration cost to recipients and will vest in four equal tranches—25% on each anniversary of the grantee’s start-date anniversary or, for four specific employees, each anniversary of 30 April 2026—subject to continued employment. Certain termination or change-of-control events could accelerate vesting.\nBased on the 8 May 2026 closing price of US$312.12 per American Depositary Share (each ADS represents 13 ordinary shares), the award has a notional market value of approximately US$7.94 million (HK$62.19 million).\nThe grant does not impose performance targets or clawback provisions, aligning with prevailing market practice and the objectives of the 2016 plan. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers exceeding relevant Hong Kong Listing Rules thresholds.\nFollowing this transaction, 61.51 million ordinary shares remain available for future equity awards under the incentive plan, including 20.40 million reserved for the consultant sub-limit.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165601096","isCrawlerRequest":true}